Phase 3 Pulmonary Arterial Hypertension PAH Clinical Trials

2 recruitingPhase 3

What is a Phase 3 trial?

Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.

Showing 1–2 of 2 trials

Recruiting

Phase 3

COMMODITIES Trial: Initial Dual Oral Therapy vs Monotherapy in PAH With Cardiovascular Comorbidities

ComorbiditiesCardiovascular Disease (CVD)Pulmonary Arterial Hypertension PAH

Assistance Publique - Hôpitaux de Paris186 enrolled1 locationNCT07245680

Recruiting

Phase 3

PAH Exercise Study

Exercise TherapyPulmonary Arterial Hypertension PAH

University of Washington10 enrolled1 locationNCT06941441